CNBC’s Meg Tirrell joins ‘Squawk Box’ to report that Biogen CEO Michel Vounatsos will step down amid the company’s troubled launch of its historic Alzheimer’s drug Aduhelm.
Get the latest creative news from FooBar about art, design and business.
Login to your account below.